Here are 20 biotechnology and pharmaceutical stocks that have been given big analyst upside targets for 2020.
Here are 11 biotech and pharma stocks that have been given big analyst upside targets for 2020.
Neovasc shares nearly doubled on Tuesday after the firm announced the submission of an application to the FDA for its Neovasc Reducer medical device for the treatment of refractory angina.
The top analyst upgrades, downgrades and initiations seen on Wednesday included Analog Devices, Halliburton, Neovasc, Nike, NXP Semiconductors, PepsiCo, Skyworks Solutions and Whiting Petroleum.
Judging by the most shorted stocks traded on the Nasdaq between the August 31 and September 14 settlement dates, those sellers were focused on Qualcomm.
Judging by the most shorted stocks traded on the Nasdaq between the August 15 and August 31 settlement dates, those sellers may have been looking for direction.
Judging by the most shorted stocks traded on the Nasdaq between the July 31 and August 15 settlement dates, those sellers were focused on one favorite -- Caesars Entertainment.
Judging by the most shorted stocks traded on the Nasdaq between the July 31 and August 15 settlement dates, those sellers were focused on one favorite -- Caesars Entertainment.
Judging by the most shorted stocks traded on the Nasdaq between the July 13 and July 31 settlement dates, those sellers were looking for direction, as moves in their favorites were mixed and modest.
Judging by the most shorted stocks traded on the Nasdaq between the June 29 and July 13 settlement dates, those sellers were cautious, as their favorites saw shrinking or flat short interest.
Judging by the most shorted stocks traded on the Nasdaq between the June 15 and June 29 settlement dates, those sellers were focused on a few of favorites.
Judging by the most shorted stocks traded on the Nasdaq between the May 31 and June 15 settlement dates, those sellers were increasing their bets in many of their favorites.
The two most-shorted Nasdaq stocks held onto their positions in the short-interest reporting period that ended on May 31. There was one big mover in an otherwise mostly calm two weeks.
Judging by the most shorted stocks traded on the Nasdaq between the April 30 and May 15 settlement dates, those sellers were looking for direction, as short interest moves were mixed and mild.